Protagonist Therapeutics Inc. logo

Protagonist Therapeutics Inc.

PTGX | NASDAQ
Chart Builder DCF Calculator
$144.98
+$1.98 (+1.38%)
At close: Sep 21, 2026, 4:00 PM ET
$145.50
+$0.52 (+0.36%)
Pre-market: Sep 22, 2026, 8:15 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
128.39M 97.25M 186.73M 125.74M 123.67M 117.36M
Short-Term Investments
438.97M 321.66M 154.89M 111.61M 203.24M 188.45M
Long-Term Investments
78.93M 140.25M n/a n/a n/a 2M
Other Long-Term Assets
n/a 225K 225K 225K 225K 450K
Receivables
4.5M 168.49M 10.33M 52K 5.33M 3.82M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a n/a 10K
Total Current Assets
577.57M 591.64M 355.58M 243.08M 340.74M 315.61M
Property-Plant & Equipment
11.69M 12.61M 2.15M 4.63M 6.73M 6.41M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
92.32M 153.08M 2.37M 4.85M 6.96M 8.86M
Total Assets
669.89M 744.73M 357.95M 247.93M 347.7M 324.47M
Account Payables
5.34M 1.62M 772K 3.64M 1.6M 3.08M
Deferred Revenue
9.55M 18.89M n/a 69K 2.5M 17.21M
Short-Term Debt
2.28M 510K n/a n/a n/a n/a
Other Current Liabilities
15.51M 12.62M 6.79M 4.97M 7.13M 6.41M
Total Current Liabilities
45.44M 47.4M 21.27M 31.18M 44.02M 40.24M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 11.68M -221K n/a n/a 121K
Total Long-Term Liabilities
9.74M 22.03M n/a 1.14M 3.66M 4.62M
Total Liabilities
55.19M 69.43M 21.27M 32.32M 47.67M 44.86M
Total Debt
10.32M 10.87M 1.14M 3.66M 5.86M 5.96M
Book Value
614.71M 675.3M 336.68M 215.61M 300.02M 279.61M
Book Value Per Share
9.67 10.38 5.93 4.40 6.48 8.13
Common Stock
1K 1K 1K n/a n/a n/a
Retained Earnings
-470.67M -340.52M -615.71M -536.76M -409.36M -283.81M
Comprehensive Income
641K -82K -105K -359K -299K 28K
Shareholders Equity
614.71M 675.3M 336.68M 215.61M 300.02M 279.61M
Total Investments
517.9M 461.92M 154.89M 111.61M 203.24M 190.45M

© 2026 bestshares.com. All rights reserved.